Vaccine Conjugates Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066729
  • May 2021
  • Pharmaceuticals
  • 116 Pages
The Vaccine Conjugates market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Vaccine Conjugates market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Bharat Biotech, Biological E, GlaxoSmithKline, plc, Merck and Company, Novartis AG, Pfizer, Inc, Sanofi Pasteur, Serum Institute of India, Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Vaccine Conjugates market along with their effects over the forecast period. Similarly, according to the region Vaccine Conjugates market research report includes the study of opportunities available in the market situation.

The Vaccine Conjugates market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Vaccine Conjugates Market:
The Vaccine Conjugates market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Bharat Biotech, Biological E, GlaxoSmithKline, plc, Merck and Company, Novartis AG, Pfizer, Inc, Sanofi Pasteur, Serum Institute of India, Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation

Vaccine Conjugates Market Segmentation Analysis:
by Disease Indication
Pneumococcal
Influenza
Diphtheria Tetanus Pertussis
Meningococcal
Type
Monovalent
Multivalent
Patient Stage
Pediatrics
Adults
Pathogen Type
Bacterial
Viral
Combination

Global Vaccine Conjugates Market Segmentation by Regions:
In regional analysis, Vaccine Conjugates market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Vaccine Conjugates market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Vaccine Conjugates Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Vaccine Conjugates Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Vaccine Conjugates Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Vaccine Conjugates Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Vaccine Conjugates Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Vaccine Conjugates market, according to the key region.
  • To study the Vaccine Conjugates market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Vaccine Conjugates market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Vaccine Conjugates research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Vaccine Conjugates market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Vaccine Conjugates market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Vaccine Conjugates market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Vaccine Conjugates market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Vaccine Conjugates market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Bharat Biotech
  • Biological E
  • GlaxoSmithKline, plc
  • Merck and Company
  • Novartis AG
  • Pfizer, Inc
  • Sanofi Pasteur
  • Serum Institute of India
  • Astellas Pharma Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Pneumococcal
  • Influenza
  • Diphtheria Tetanus Pertussis
  • Meningococcal
  • Bacterial
  • Viral
  • Combination

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Vaccine Conjugates Market Snapshot
          2.1.1. Global Vaccine Conjugates Market By Disease Indication,2019
               2.1.1.1.Pneumococcal
               2.1.1.2.Influenza
               2.1.1.3.Diphtheria Tetanus Pertussis
               2.1.1.4.Meningococcal
          2.1.2. Global Vaccine Conjugates Market By Pathogen Type,2019
               2.1.2.1.Bacterial
               2.1.2.2.Viral
               2.1.2.3.Combination
          2.1.3. Global Vaccine Conjugates Market By End-use,2019
          2.1.4. Global Vaccine Conjugates Market By Geography,2019

3. Global Vaccine Conjugates Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Vaccine Conjugates Market Size (US$), By Disease Indication, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Disease Indication, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Disease Indication, 2020
     4.2. Global Vaccine Conjugates Market Size (US$), By Disease Indication, 2018 – 2028

5. Global Vaccine Conjugates Market Size (US$), By Pathogen Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Pathogen Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Pathogen Type, 2020
     5.2. Global Vaccine Conjugates Market Size (US$), By Pathogen Type, 2018 – 2028

6. Global Vaccine Conjugates Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Vaccine Conjugates Market Size (US$), By End-use, 2018 – 2028

7. Global Vaccine Conjugates Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Vaccine Conjugates Market Analysis, 2018 – 2028 
          7.2.1. North America Vaccine Conjugates Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Vaccine Conjugates Market Size (US$), By Disease Indication, 2018 – 2028
          7.2.3. North America Vaccine Conjugates Market Size (US$), By Pathogen Type, 2018 – 2028
          7.2.4. North America Vaccine Conjugates Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Vaccine Conjugates Market Analysis, 2018 – 2028 
          7.3.1.  Europe Vaccine Conjugates Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Vaccine Conjugates Market Size (US$), By Disease Indication, 2018 – 2028
          7.3.3. Europe Vaccine Conjugates Market Size (US$), By Pathogen Type, 2018 – 2028
          7.3.4. Europe Vaccine Conjugates Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Vaccine Conjugates Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Vaccine Conjugates Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Vaccine Conjugates Market Size (US$), By Disease Indication, 2018 – 2028
          7.4.3. Asia Pacific Vaccine Conjugates Market Size (US$), By Pathogen Type, 2018 – 2028
          7.4.4. Asia Pacific Vaccine Conjugates Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Vaccine Conjugates Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Vaccine Conjugates Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Vaccine Conjugates Market Size (US$), By Disease Indication, 2018 – 2028
          7.5.3. Latin America Vaccine Conjugates Market Size (US$), By Pathogen Type, 2018 – 2028
          7.5.4. Latin America Vaccine Conjugates Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Vaccine Conjugates Market Analysis, 2018 – 2028 
          7.6.1.  MEA Vaccine Conjugates Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Vaccine Conjugates Market Size (US$), By Disease Indication, 2018 – 2028
          7.6.3. MEA Vaccine Conjugates Market Size (US$), By Pathogen Type, 2018 – 2028
          7.6.4. MEA Vaccine Conjugates Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Vaccine Conjugates Providers
        8.4.1 Bharat Biotech
                8.4.1.1 Business Description
                8.4.1.2 Bharat Biotech Geographic Operations
                8.4.1.3 Bharat Biotech Financial Information
                8.4.1.4 Bharat Biotech Product Positions/Portfolio
                8.4.1.5 Bharat Biotech Key Developments
        8.4.2 Biological E
                8.4.2.1 Business Description
                8.4.2.2 Biological E Geographic Operations
                8.4.2.3 Biological E Financial Information
                8.4.2.4 Biological E Product Positions/Portfolio
                8.4.2.5 Biological E Key Developments
        8.4.3 GlaxoSmithKline, plc
                8.4.3.1 Business Description
                8.4.3.2 GlaxoSmithKline, plc Geographic Operations
                8.4.3.3 GlaxoSmithKline, plc Financial Information
                8.4.3.4 GlaxoSmithKline, plc Product Positions/Portfolio
                8.4.3.5 GlaxoSmithKline, plc Key Developments
        8.4.4 Merck and Company
                8.4.4.1 Business Description
                8.4.4.2 Merck and Company Geographic Operations
                8.4.4.3 Merck and Company Financial Information
                8.4.4.4 Merck and Company Product Positions/Portfolio
                8.4.4.5 Merck and Company Key Developments
        8.4.5 Novartis AG
                8.4.5.1 Business Description
                8.4.5.2 Novartis AG Geographic Operations
                8.4.5.3 Novartis AG Financial Information
                8.4.5.4 Novartis AG Product Positions/Portfolio
                8.4.5.5 Novartis AG Key Developments
        8.4.6 Pfizer, Inc
                8.4.6.1 Business Description
                8.4.6.2 Pfizer, Inc Geographic Operations
                8.4.6.3 Pfizer, Inc Financial Information
                8.4.6.4 Pfizer, Inc Product Positions/Portfolio
                8.4.6.5 Pfizer, Inc Key Developments
        8.4.7 Sanofi Pasteur
                8.4.7.1 Business Description
                8.4.7.2 Sanofi Pasteur Geographic Operations
                8.4.7.3 Sanofi Pasteur Financial Information
                8.4.7.4 Sanofi Pasteur Product Positions/Portfolio
                8.4.7.5 Sanofi Pasteur Key Developments
        8.4.8 Serum Institute of India
                8.4.8.1 Business Description
                8.4.8.2 Serum Institute of India Geographic Operations
                8.4.8.3 Serum Institute of India Financial Information
                8.4.8.4 Serum Institute of India Product Positions/Portfolio
                8.4.8.5 Serum Institute of India Key Developments
        8.4.9 Astellas Pharma Inc.
                8.4.9.1 Business Description
                8.4.9.2 Astellas Pharma Inc. Geographic Operations
                8.4.9.3 Astellas Pharma Inc. Financial Information
                8.4.9.4 Astellas Pharma Inc. Product Positions/Portfolio
                8.4.9.5 Astellas Pharma Inc. Key Developments
        8.4.10 Mitsubishi Tanabe Pharma Corporation
                8.4.10.1 Business Description
                8.4.10.2 Mitsubishi Tanabe Pharma Corporation Geographic Operations
                8.4.10.3 Mitsubishi Tanabe Pharma Corporation Financial Information
                8.4.10.4 Mitsubishi Tanabe Pharma Corporation Product Positions/Portfolio
                8.4.10.5 Mitsubishi Tanabe Pharma Corporation Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Vaccine Conjugates Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Vaccine Conjugates Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Vaccine Conjugates Market Revenue, By Pathogen Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Vaccine Conjugates Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Vaccine Conjugates Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Vaccine Conjugates Market Revenue, By Pathogen Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Vaccine Conjugates Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Vaccine Conjugates Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Vaccine Conjugates Market Revenue, By Pathogen Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Vaccine Conjugates Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Vaccine Conjugates Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Vaccine Conjugates Market Revenue, By Pathogen Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Vaccine Conjugates Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Vaccine Conjugates Market Revenue, By Disease Indication, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Vaccine Conjugates Market Revenue, By Pathogen Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Vaccine Conjugates Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Vaccine Conjugates: Market Segmentation 
FIG. 2 Global Vaccine Conjugates Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Vaccine Conjugates Market, By Disease Indication, 2019 (US$ Mn) 
FIG. 5 Global Vaccine Conjugates Market, By Pathogen Type, 2019 (US$ Mn) 
FIG. 6 Global Vaccine Conjugates Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Vaccine Conjugates Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Vaccine Conjugates Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Vaccine Conjugates Providers, 2019
FIG. 11 Global Vaccine Conjugates Market Revenue Contribution, By Disease Indication, 2019 & 2028 (Value %) 
FIG. 12 Global Vaccine Conjugates Market Revenue Contribution, By Pathogen Type, 2019 & 2028 (Value %) 
FIG. 13 Global Vaccine Conjugates Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Vaccine Conjugates Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Vaccine Conjugates Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Vaccine Conjugates Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Vaccine Conjugates Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Vaccine Conjugates Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Vaccine Conjugates market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Vaccine Conjugates Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Vaccine Conjugates Market Value, By Segment1, 2018 – 2028
TABLE  North America Vaccine Conjugates Market Value, By Segment2, 2018 – 2028
TABLE  North America Vaccine Conjugates Market Value, By Country, 2018 – 2028
TABLE  Europe Vaccine Conjugates Market Value, By Segment1, 2018 – 2028
TABLE  Europe Vaccine Conjugates Market Value, By Segment2, 2018 – 2028
TABLE  Europe Vaccine Conjugates Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Vaccine Conjugates Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Vaccine Conjugates Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Vaccine Conjugates Market Value, By Country, 2018 – 2028
TABLE  Latin America Vaccine Conjugates Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Vaccine Conjugates Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Vaccine Conjugates Market Value, By Country, 2018 – 2028
TABLE  MEA Vaccine Conjugates Market Value, By Segment1, 2018 – 2028
TABLE  MEA Vaccine Conjugates Market Value, By Segment2, 2018 – 2028
TABLE  MEA Vaccine Conjugates Market Value, By Country, 2018 – 2028
TABLE  Bharat Biotech: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biological E: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline, plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi Pasteur: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Serum Institute of India: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Astellas Pharma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mitsubishi Tanabe Pharma Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Vaccine Conjugates Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Vaccine Conjugates Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Vaccine Conjugates Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Vaccine Conjugates Market, By Geography, 2019 (US$ Mn)
FIG.  Global Vaccine Conjugates Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Vaccine Conjugates Providers, 2016
FIG.  Global Vaccine Conjugates Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Influenza Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diphtheria Tetanus Pertussis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Meningococcal Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Vaccine Conjugates Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Viral Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Combination Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Vaccine Conjugates Market Value, 2018 – 2028, (US$ Mn)